Indication

Disseminated aspergillosis

Disseminated aspergillosis is a severe, life-threatening form of invasive fungal disease caused by *Aspergillus* species, most frequently *Aspergillus fumigatus*. Read more about Disseminated aspergillosis

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Disseminated aspergillosis therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Disseminated aspergillosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Disseminated aspergillosis.

Disseminated aspergillosis is a severe, life-threatening form of invasive fungal disease caused by *Aspergillus* species, most frequently *Aspergillus fumigatus*.

It primarily occurs in severely immunocompromised hosts, such as patients with prolonged neutropenia, hematologic malignancies, or hematopoietic stem cell and solid organ transplants, as well as those receiving intensive immunosuppressive therapy.

Pathophysiologically, fungal hyphae exhibit angioinvasion from a primary site—typically the lungs or paranasal sinuses—resulting in vascular thrombosis, tissue infarction, and hematogenous seeding across two or more noncontiguous organ systems.

Clinically, it manifests as refractory fever and rapid multiorgan decline, commonly involving metastatic foci in the central nervous system, skin, kidneys, liver, and bones.

Personalize your experience

Follow Disseminated aspergillosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it